Morgane Le Gall

The protein-protein interaction landscape of Fanconi anemia protein A (FANCA) reveals its contributions to mRNA processes.

The paper identifies new protein interactions of FANCA, revealing its roles in mRNA processes beyond DNA repair, and suggests potential therapeutic targets for Fanconi anemia.

DiPRO1 dependent transcriptional and epigenetic regulation distinctly controls the fate of muscle and mesenchymal cancer cells.

This paper identifies DiPRO1 as a regulator of myoblast differentiation and mesenchymal tumor suppression through epigenetic and transcriptional mechanisms, showing its potential as a therapeutic target.

T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including Hepatocyte Growth factor

This study identifies an inflammatory microenvironment in T-ALL that supports progression, with HGF as a potential therapeutic target.

LRRFIP2 modulates the response to hypoxia during embryonic cardiogenesis

This study identifies LRRFIP2 as a negative regulator of HIF-1 activity in cardiomyocytes, showing its role in modulating hypoxia response during embryonic heart development.